Prisco D, Conti A A, Giurlani L, Falciani M
Istituto di Clinica Medica Generale e Cardiologia, Università degli Studi di Firenze.
Ann Ital Med Int. 1998 Apr-Jun;13(2):81-7.
The aim of this paper is to review fibrinolysis laboratory tests of potential clinical usefulness. Since the activation of the fibrinolytic system may be responsible for several relevant pathological scenarios, it is crucial to know whether and to what extent fibrinolysis laboratory tests are useful for the diagnosis and therapy of individual patients. The plasma fibrinolytic system may be altered by deficiencies and/or abnormalities of some of its components. Few doubts remain concerning the possible role of fibrinolysis alterations in the pathophysiology of some hemorrhagic and thrombotic disorders. In hemorrhagic patients, laboratory tests may demonstrate the existence of increased plasmin activity and the presence of specific congenital defects leading to primary hyperfibrinolysis. Alterations of the fibrinolytic system should be looked for only in selected patients who have a history of venous thrombosis and negative results of initial screening tests.
本文旨在综述具有潜在临床应用价值的纤维蛋白溶解实验室检测。由于纤维蛋白溶解系统的激活可能与多种相关病理情况有关,因此了解纤维蛋白溶解实验室检测对个体患者的诊断和治疗是否有用以及有用程度至关重要。血浆纤维蛋白溶解系统可能会因其某些成分的缺乏和/或异常而发生改变。关于纤维蛋白溶解改变在某些出血性和血栓性疾病病理生理学中的可能作用,几乎没有疑问。在出血患者中,实验室检测可能会显示纤溶酶活性增加以及导致原发性纤维蛋白溶解的特定先天性缺陷的存在。仅应在有静脉血栓形成病史且初始筛查试验结果为阴性的特定患者中寻找纤维蛋白溶解系统的改变。